Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Jones

Showing results (191-200 of 250) with videos related to

Pageof 25
Sort By:
Gastroenterology|February 1, 1986
Selective immunoglobulin A deficiency associated with primary biliary cirrhosis in a family with liver diseaseS P James, E A Jones, D F Schafer, et al.
Revista Espanola De Enfermedades Digestivas|July 13, 2010
Hepatic fibrosis in patients with chronic hepatitis C assessed by transient elastography: implications for determining the efficacy of antiviral therapyJ Mendoza, M Trapero-Marugán, L González-Moreno, et al.
Journal of Medical Genetics|June 23, 2009
Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testingD G R Evans, F Lalloo, A Cramer, et al.
The Journal of Clinical Investigation|September 1, 1972
Quantitative studies of the delivery of hepatic-synthesized bilirubin to plasma utilizing -aminolevulinic acid-4- 14 C and bilirubin- 3 H in manE A Jones, R Shrager, J R Bloomer, et al.
Gut|March 1, 1986
Anticomplement receptor activity in the serum of patients with primary biliary cirrhosisG Y Minuk, J Vergalla, R G Hanson, et al.
Clinical and Experimental Immunology|August 1, 1996
Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB)M Shindo, G E Mullin, L Braun-Elwert, et al.
Hepatology (Baltimore, Md.)|October 1, 1989
Defective immunoregulation in primary biliary cirrhosis: CD4+, Leu-8+ T cells have abnormal activation and suppressor function in vitroT Suou, M P Civeira, M E Kanof, et al.
Digestive Diseases and Sciences|October 28, 1998
Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapyF ter Borg, S Smorenburg, R A de Man, et al.
European Journal of Gastroenterology & Hepatology|October 19, 1999
Combination therapy with mycophenolate mofetil and ursodeoxycholic acid for primary biliary cirrhosisE A Jones, F J ten Kate, F ter Borg, et al.
Annals of Internal Medicine|June 1, 1981
Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitisJ H Hoofnagle, G M Dusheiko, L B Seeff, et al.
Pageof 25

Showing results (191-200 of 250) with videos related to

Sort By:
Pageof 25
Gastroenterology|February 1, 1986
Selective immunoglobulin A deficiency associated with primary biliary cirrhosis in a family with liver diseaseS P James, E A Jones, D F Schafer, et al.
Revista Espanola De Enfermedades Digestivas|July 13, 2010
Hepatic fibrosis in patients with chronic hepatitis C assessed by transient elastography: implications for determining the efficacy of antiviral therapyJ Mendoza, M Trapero-Marugán, L González-Moreno, et al.
Journal of Medical Genetics|June 23, 2009
Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testingD G R Evans, F Lalloo, A Cramer, et al.
The Journal of Clinical Investigation|September 1, 1972
Quantitative studies of the delivery of hepatic-synthesized bilirubin to plasma utilizing -aminolevulinic acid-4- 14 C and bilirubin- 3 H in manE A Jones, R Shrager, J R Bloomer, et al.
Gut|March 1, 1986
Anticomplement receptor activity in the serum of patients with primary biliary cirrhosisG Y Minuk, J Vergalla, R G Hanson, et al.
Clinical and Experimental Immunology|August 1, 1996
Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB)M Shindo, G E Mullin, L Braun-Elwert, et al.
Hepatology (Baltimore, Md.)|October 1, 1989
Defective immunoregulation in primary biliary cirrhosis: CD4+, Leu-8+ T cells have abnormal activation and suppressor function in vitroT Suou, M P Civeira, M E Kanof, et al.
Digestive Diseases and Sciences|October 28, 1998
Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapyF ter Borg, S Smorenburg, R A de Man, et al.
European Journal of Gastroenterology & Hepatology|October 19, 1999
Combination therapy with mycophenolate mofetil and ursodeoxycholic acid for primary biliary cirrhosisE A Jones, F J ten Kate, F ter Borg, et al.
Annals of Internal Medicine|June 1, 1981
Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitisJ H Hoofnagle, G M Dusheiko, L B Seeff, et al.
Pageof 25